CELL:CaMKII 的重新激活可保护视神经细胞以防止青光眼视力丧失

2021-07-26 网络 网络

青光眼(glaucoma )是一组具有特征性视神经损害和视野缺损的眼病。世界卫生组织已将它列为世界范围内的第二大致盲性眼部疾病。它主要跟眼内压升高有关,眼压升高压迫视神经,导致视野缺损甚至失

青光眼(glaucoma )是一组具有特征性视神经损害和视野缺损的眼病。世界卫生组织已将它列为世界范围内的第二大致盲性眼部疾病。它主要跟眼内压升高有关,眼压升高压迫视神经,导致视野缺损甚至失明。视神经是视网膜神经节细胞的轴突束,可将信号从眼睛传递到大脑以产生视力。视网膜神经节细胞 (RGC) 是将视觉信息从视网膜传输到大脑的唯一输出神经元。多种损伤和病理状态会导致 RGC 胞体和轴突退化,导致不可逆的视力丧失。

目前可用的疗法是通过降低升高的眼压来减缓视力丧失,但是尽管眼压正常,一些青光眼仍会发展为失明。神经保护疗法将是一个飞跃,满足缺乏治疗选择的患者的需求。那操纵 RGC 存活的关键调节器是否可以保护 RGC 免受各种损伤和病理状态的影响,并最终保护视力呢?

近期,一项发表在《细胞》(CELL)上的一项研究发现一种基因疗法可以保护视神经细胞并保护青光眼小鼠模型的视力。这些发现为开发青光眼神经保护疗法提供了一条前进道路。该研究首次表明CaMKII 的重新激活可保护多种损伤/疾病模型中的 RGC。

CaMKII(钙/钙调蛋白依赖性蛋白激酶 II)通路调节整个身体的关键细胞过程和功能,包括眼睛中的视网膜神经节细胞。

该研究团队发现,每当视网膜神经节细胞暴露于毒素或视神经挤压伤造成的创伤时,CaMKII 通路信号就会受到损害,这表明 CaMKII 活性与视网膜神经节细胞存活之间存在相关性。

在寻找干预方法时,他们发现通过基因治疗激活 CaMKII 通路证明对视网膜神经节细胞具有保护作用。在毒性损伤之前(对细胞造成快速损伤)和视神经挤压(引起较慢的损伤)之后对小鼠进行基因治疗,增加了 CaMKII 活性并有力地保护了视网膜神经节细胞。

在接受基因治疗的小鼠中,77% 的视网膜神经节细胞在中毒后 12 个月存活,而对照组小鼠则为 8%。视神经挤压六个月后,77% 的视网膜神经节细胞存活,而对照组为 7%。同样,在基于眼压升高或遗传缺陷的青光眼模型中,通过基因治疗提高 CaMKII 活性证明对视网膜神经节细胞有保护作用。

根据视网膜电图测量的细胞活动和视觉皮层的活动模式,增加的视网膜神经节细胞存活率转化为更大的保留视觉功能的可能性。与未接受治疗的小鼠相比,接受治疗的小鼠在展示旨在模拟威胁的头顶刺激时更容易做出防御性反应(通过躲藏、冻结或摇尾)。

“如果我们使视网膜神经节细胞对导致青光眼细胞死亡的损伤更具抵抗力和耐受性,它们可能能够存活更长时间并保持其功能,”陈总结道。

 

1. 参考文献:Xinzheng Guo, Jing Zhou, Christopher Starr, Ethan J. Mohns, Yidong Li, Earnest P. Chen, Yonejung Yoon, Christopher P. Kellner, Kohichi Tanaka, Hongbing Wang, Wei Liu, Louis R. Pasquale, Jonathan B. Demb, Michael C. Crair, Bo Chen. Preservation of vision after CaMKII-mediated protection of retinal ganglion cells. Cell, 2021; DOI: 10.1016/j.cell.2021.06.031

 

评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1814629, encodeId=bb0b181462951, content=<a href='/topic/show?id=f8f795864d9' target=_blank style='color:#2F92EE;'>#重新激活#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95864, encryptionId=f8f795864d9, topicName=重新激活)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Fri Nov 05 08:16:42 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954110, encodeId=fdec19541104f, content=<a href='/topic/show?id=e369400476' target=_blank style='color:#2F92EE;'>#CaMKII#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4004, encryptionId=e369400476, topicName=CaMKII)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 08 22:16:42 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667020, encodeId=6e0a166e02071, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Wed May 25 06:16:42 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872257, encodeId=fc8f18e2257bf, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Jun 21 18:16:42 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675376, encodeId=79b716e5376d4, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Thu Nov 11 10:16:42 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962570, encodeId=bdec19625e0fc, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 11 23:16:42 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489565, encodeId=34231489565a4, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600760, encodeId=b50c1600e60bd, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2021-11-05 lg.zhao
  2. [GetPortalCommentsPageByObjectIdResponse(id=1814629, encodeId=bb0b181462951, content=<a href='/topic/show?id=f8f795864d9' target=_blank style='color:#2F92EE;'>#重新激活#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95864, encryptionId=f8f795864d9, topicName=重新激活)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Fri Nov 05 08:16:42 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954110, encodeId=fdec19541104f, content=<a href='/topic/show?id=e369400476' target=_blank style='color:#2F92EE;'>#CaMKII#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4004, encryptionId=e369400476, topicName=CaMKII)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 08 22:16:42 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667020, encodeId=6e0a166e02071, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Wed May 25 06:16:42 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872257, encodeId=fc8f18e2257bf, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Jun 21 18:16:42 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675376, encodeId=79b716e5376d4, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Thu Nov 11 10:16:42 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962570, encodeId=bdec19625e0fc, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 11 23:16:42 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489565, encodeId=34231489565a4, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600760, encodeId=b50c1600e60bd, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2021-10-08 仁医06

    #CaMKII#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1814629, encodeId=bb0b181462951, content=<a href='/topic/show?id=f8f795864d9' target=_blank style='color:#2F92EE;'>#重新激活#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95864, encryptionId=f8f795864d9, topicName=重新激活)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Fri Nov 05 08:16:42 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954110, encodeId=fdec19541104f, content=<a href='/topic/show?id=e369400476' target=_blank style='color:#2F92EE;'>#CaMKII#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4004, encryptionId=e369400476, topicName=CaMKII)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 08 22:16:42 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667020, encodeId=6e0a166e02071, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Wed May 25 06:16:42 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872257, encodeId=fc8f18e2257bf, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Jun 21 18:16:42 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675376, encodeId=79b716e5376d4, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Thu Nov 11 10:16:42 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962570, encodeId=bdec19625e0fc, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 11 23:16:42 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489565, encodeId=34231489565a4, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600760, encodeId=b50c1600e60bd, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2022-05-25 gj0740
  4. [GetPortalCommentsPageByObjectIdResponse(id=1814629, encodeId=bb0b181462951, content=<a href='/topic/show?id=f8f795864d9' target=_blank style='color:#2F92EE;'>#重新激活#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95864, encryptionId=f8f795864d9, topicName=重新激活)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Fri Nov 05 08:16:42 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954110, encodeId=fdec19541104f, content=<a href='/topic/show?id=e369400476' target=_blank style='color:#2F92EE;'>#CaMKII#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4004, encryptionId=e369400476, topicName=CaMKII)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 08 22:16:42 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667020, encodeId=6e0a166e02071, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Wed May 25 06:16:42 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872257, encodeId=fc8f18e2257bf, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Jun 21 18:16:42 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675376, encodeId=79b716e5376d4, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Thu Nov 11 10:16:42 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962570, encodeId=bdec19625e0fc, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 11 23:16:42 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489565, encodeId=34231489565a4, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600760, encodeId=b50c1600e60bd, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2022-06-21 zhaozhouchifen

    #Cell#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1814629, encodeId=bb0b181462951, content=<a href='/topic/show?id=f8f795864d9' target=_blank style='color:#2F92EE;'>#重新激活#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95864, encryptionId=f8f795864d9, topicName=重新激活)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Fri Nov 05 08:16:42 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954110, encodeId=fdec19541104f, content=<a href='/topic/show?id=e369400476' target=_blank style='color:#2F92EE;'>#CaMKII#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4004, encryptionId=e369400476, topicName=CaMKII)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 08 22:16:42 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667020, encodeId=6e0a166e02071, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Wed May 25 06:16:42 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872257, encodeId=fc8f18e2257bf, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Jun 21 18:16:42 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675376, encodeId=79b716e5376d4, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Thu Nov 11 10:16:42 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962570, encodeId=bdec19625e0fc, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 11 23:16:42 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489565, encodeId=34231489565a4, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600760, encodeId=b50c1600e60bd, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2021-11-11 whmdzju

    #CAM#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1814629, encodeId=bb0b181462951, content=<a href='/topic/show?id=f8f795864d9' target=_blank style='color:#2F92EE;'>#重新激活#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95864, encryptionId=f8f795864d9, topicName=重新激活)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Fri Nov 05 08:16:42 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954110, encodeId=fdec19541104f, content=<a href='/topic/show?id=e369400476' target=_blank style='color:#2F92EE;'>#CaMKII#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4004, encryptionId=e369400476, topicName=CaMKII)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 08 22:16:42 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667020, encodeId=6e0a166e02071, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Wed May 25 06:16:42 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872257, encodeId=fc8f18e2257bf, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Jun 21 18:16:42 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675376, encodeId=79b716e5376d4, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Thu Nov 11 10:16:42 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962570, encodeId=bdec19625e0fc, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 11 23:16:42 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489565, encodeId=34231489565a4, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600760, encodeId=b50c1600e60bd, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2022-05-11 维他命

    #CEL#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1814629, encodeId=bb0b181462951, content=<a href='/topic/show?id=f8f795864d9' target=_blank style='color:#2F92EE;'>#重新激活#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95864, encryptionId=f8f795864d9, topicName=重新激活)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Fri Nov 05 08:16:42 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954110, encodeId=fdec19541104f, content=<a href='/topic/show?id=e369400476' target=_blank style='color:#2F92EE;'>#CaMKII#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4004, encryptionId=e369400476, topicName=CaMKII)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 08 22:16:42 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667020, encodeId=6e0a166e02071, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Wed May 25 06:16:42 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872257, encodeId=fc8f18e2257bf, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Jun 21 18:16:42 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675376, encodeId=79b716e5376d4, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Thu Nov 11 10:16:42 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962570, encodeId=bdec19625e0fc, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 11 23:16:42 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489565, encodeId=34231489565a4, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600760, encodeId=b50c1600e60bd, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2021-07-28 liye789132254
  8. [GetPortalCommentsPageByObjectIdResponse(id=1814629, encodeId=bb0b181462951, content=<a href='/topic/show?id=f8f795864d9' target=_blank style='color:#2F92EE;'>#重新激活#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95864, encryptionId=f8f795864d9, topicName=重新激活)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c737344, createdName=lg.zhao, createdTime=Fri Nov 05 08:16:42 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954110, encodeId=fdec19541104f, content=<a href='/topic/show?id=e369400476' target=_blank style='color:#2F92EE;'>#CaMKII#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4004, encryptionId=e369400476, topicName=CaMKII)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Oct 08 22:16:42 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1667020, encodeId=6e0a166e02071, content=<a href='/topic/show?id=5fda90e061e' target=_blank style='color:#2F92EE;'>#视神经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=191, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90706, encryptionId=5fda90e061e, topicName=视神经)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14db26078051, createdName=gj0740, createdTime=Wed May 25 06:16:42 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1872257, encodeId=fc8f18e2257bf, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Tue Jun 21 18:16:42 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675376, encodeId=79b716e5376d4, content=<a href='/topic/show?id=cb8a400091' target=_blank style='color:#2F92EE;'>#CAM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4000, encryptionId=cb8a400091, topicName=CAM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16ac27217804, createdName=whmdzju, createdTime=Thu Nov 11 10:16:42 CST 2021, time=2021-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1962570, encodeId=bdec19625e0fc, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed May 11 23:16:42 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1489565, encodeId=34231489565a4, content=<a href='/topic/show?id=362fe4482f1' target=_blank style='color:#2F92EE;'>#神经细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74482, encryptionId=362fe4482f1, topicName=神经细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81b08562535, createdName=liye789132254, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1600760, encodeId=b50c1600e60bd, content=<a href='/topic/show?id=57fd9066930' target=_blank style='color:#2F92EE;'>#视力丧失#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90669, encryptionId=57fd9066930, topicName=视力丧失)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d71518802846, createdName=shanyongle, createdTime=Wed Jul 28 04:16:42 CST 2021, time=2021-07-28, status=1, ipAttribution=)]
    2021-07-28 shanyongle

相关资讯

基因治疗出岔子了?蓝鸟(Bluebird Bio)暂停LentiGlobin基因疗法1/2、3期临床研究

美国当地时间2021年2月16日,著名的基因疗法公司蓝鸟生物(bluebird bio, Inc.)宣布,由于可疑的非预期严重不良反应急性髓细胞白血病(AML),公司已经

细胞与基因治疗方兴未艾,中国细胞产业生态圈扩张加速

上海张江有望诞生中国首个细胞药物

JCI Insight:VEGF-A165基因治疗可改善血-迷路屏障破裂和听力损失

数百万人受到听力损失的影响。如果听力损失是由噪音或衰老引起的,通常与耳蜗及其血管之间的屏障破裂有关。

Nat Commun:基因治疗:法布里病的潜在治疗策略

法布里(Fabry)病是一种由X染色体连锁的GLA基因突变诱导的多系统溶酶体贮积病。其会导致对肾脏、心脏和大脑等终末器官造成损害,导致患者预期寿命的降低。

Science:最“安全”基因治疗载体似乎并不安全,血友病患者接受治疗后患上肝癌

荷兰生物制药公司uniQure的一项针对B型血友病的基因疗法被美国FDA叫停,起因是接受治疗后该患者患上了肝细胞癌。

iScience:基因治疗在儿童盲症患者中初显希望

基因治疗或成为治疗儿童盲症的希望!

拓展阅读

JAMA Ophthalmol:光学相干断层扫描血管成像可平均提前 2.3 年捕捉青光眼进展,多模态监测迎来新证据

OCTA血管密度指标可早于传统OCT结构检测和视野检查发现青光眼进展,具备优异的早期筛查价值,尤其适用于中晚期青光眼病情监测。

Lancet子刊:仅需基线彩照即可评估远期风险,青光眼诊疗迎来 AI 辅助新工具

本研究开发的 G-PROG 深度学习模型,可仅依靠单张基线彩色眼底照预测患者未来 2-5 年的青光眼结构性进展速率,且在 5 个国际多中心队列中获得了稳定的外部验证效果。

告别直视依赖:这项技术让复杂青光眼手术更安全可控

该技术完整保留了 GATT 术式微创、符合生理引流的核心优势,同时通过光学原理的巧妙应用,解决了复杂临床场景下的定位难题,具备极强的临床可复制性与推广价值。

JAMA 子刊:烟酰胺降低 66% 青光眼风险,高眼压人群迎来预防新方案

烟酰胺安全性良好、可及性高,本研究为青光眼的代谢靶向预防提供了关键真实世界证据,但其最优剂量、长期安全性与确切疗效仍需前瞻性随机对照试验进一步验证。

荷兰万人研究:饮食质量越高,青光眼患病率越低

该研究的创新之处在于首次系统评估了国家膳食指南依从性与青光眼的关联,其采用的DHD-index基于荷兰人群的饮食习惯制定,具有更强的实用性和可推广性。

Lancet Primary Care:告别高漏诊、高成本!AI 赋能青光眼初级筛查,敏感性 78%、特异性 95% 获验证

初级卫生保健中的AI青光眼筛查具有良好成本效益,可减少不必要的专家转诊,虽单次筛查可能遗漏部分病例,但结合眼压测量和长期重复筛查可有效弥补。

2025 EGS指南:青光眼的术语和管理(第6版)

欧洲青光眼学会(EGS,European Glaucoma Society) · 2025-09-08